RECURSION PHARMACEUTICALS, INC. 4

Blake Borgeson sold 30,000 shares of Recursion Pharmaceuticals, Inc. Class A Common Stock at $3.25 per share under a Rule 10b5-1 plan.

On 2026-08-04, reporting person Blake Borgeson, an insider of Recursion Pharmaceuticals, Inc., sold 30,000 shares of Class A Common Stock at an average price of $3.25 per share, for total proceeds of approximately $97,500. The transaction, reported as an open market or similar sale, was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 31, 2025, indicating a pre-scheduled diversification or liquidity event rather than an opportunistic trade. Following this sale, Borgeson continued to hold 6,188,287 shares directly, representing a substantial ongoing equity stake in the company; using the transaction price as a proxy, the post-transaction holdings are valued at roughly $20.11 million.

Filing Facts

CIK

1601830

Ticker

RXRX

Form

4

Source Type

fda

Accession

0001856094-26-000014

Alert Tier

5